Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$17.29 - $21.74 $283,556 - $356,536
-16,400 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.51 - $24.28 $17,559 - $21,852
900 Added 5.81%
16,400 $320,000
Q2 2019

Aug 09, 2019

BUY
$21.47 - $37.33 $332,785 - $578,615
15,500 New
15,500 $349,000
Q4 2018

Feb 14, 2019

SELL
$27.94 - $44.61 $349,250 - $557,625
-12,500 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $19,300 - $23,060
-500 Reduced 3.85%
12,500 $530,000
Q2 2018

Aug 13, 2018

SELL
$40.56 - $51.36 $20,280 - $25,680
-500 Reduced 3.7%
13,000 $535,000
Q1 2018

May 14, 2018

BUY
$53.61 - $67.26 $5,361 - $6,726
100 Added 0.75%
13,500 $782,000
Q4 2017

Feb 13, 2018

SELL
$47.69 - $55.39 $114,456 - $132,936
-2,400 Reduced 15.19%
13,400 $733,000
Q3 2017

Nov 13, 2017

BUY
$49.16 - $54.45 $776,728 - $860,310
15,800
15,800 $807,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.